Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy

In this work, we focused on mesoporous silica nanoparticles (MSN) for one photon excitated photodynamic therapy (OPE-PDT) combined with drug delivery and carbohydrate targeting applied on retinoblastoma, a rare disease of childhood. We demonstrate that bitherapy (camptothecin delivery and photodynam...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics Vol. 432; no. 1-2; pp. 99 - 104
Main Authors: Gary-Bobo, Magali, Mir, Youssef, Rouxel, Cédric, Brevet, David, Hocine, Ouahiba, Maynadier, Marie, Gallud, Audrey, Da Silva, Afitz, Mongin, Olivier, Blanchard-Desce, Mireille, Richeter, Sébastien, Loock, Bernard, Maillard, Philippe, Morère, Alain, Garcia, Marcel, Raehm, Laurence, Durand, Jean-Olivier
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01-08-2012
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this work, we focused on mesoporous silica nanoparticles (MSN) for one photon excitated photodynamic therapy (OPE-PDT) combined with drug delivery and carbohydrate targeting applied on retinoblastoma, a rare disease of childhood. We demonstrate that bitherapy (camptothecin delivery and photodynamic therapy) performed with MSN on retinoblastoma cancer cells was efficient in inducing cancer cell death. Alternatively MSN designed for two-photon excited photodynamic therapy (TPE-PDT) were also studied and irradiation at low fluence efficiently killed retinoblastoma cancer cells.
Bibliography:http://dx.doi.org/10.1016/j.ijpharm.2012.04.056
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2012.04.056